Corporate

Zandu Pharma Q1 profit doubles at Rs 11.12 cr

Zandu Pharmaceutical Works, the manufacturer of ayurvedic health care products, today reported a growth of over twofold in its net profit for the quarter ended June at Rs 11.12 crore, over the corresponding period a year ago. - Ranbaxy gets Canada"s nod to mkt anti-hypertension drug - Teva Pharma recalls anti-anxiety drug Propofol - Shasun to invest Rs 100 cr for setting up new Vizag plant - Pharma, healthcare industry disappointed with Budget - Duties on life-saving drugs reduced - Orchid Chem gets US FDA nod for anti-hypertensive drug The company had a net profit of Rs 4.94 crore during the June quarter a year earlier, Zandu Pharma said in a filing to the Bombay Stock Exchange (BSE). Total income rose marginally to Rs 31.91 crore in the latest quarter of the current fiscal from Rs 30.93 crore in the same period last fiscal. Shares of Zandu Pharma today settled the trade at Rs 7,100.35, up 10.36 per cent from its previous close on the BSE.

Add your comment:

Name:
Site address:	http://
Your message:
Enter today\\\\'s date, 2 digits (spam protection):